Introduction {#S1}
============

Human rhinoviruses (HRVs) are ubiquitous single stranded RNA viruses that are responsible for most common cold cases. In healthy people, HRV infections generally cause relatively minor symptoms and are largely of nuisance value. However, this innocuous virus can have serious consequences in immunosuppressed individuals. HRV infections have also been linked to the onset of asthma in young children and to severe exacerbations of established asthma and chronic obstructive pulmonary disease ([@B1]--[@B3]). There is thus considerable interest in understanding the pathogenesis of HRV infections and the factors that mediate host protection against this virus.

Type I interferons (IFN-Is), including the various IFN-α subtypes and IFN-β, are important mediators of host protection against virus infections. Lack of IFN-I production can lead to reduced antiviral responses enabling higher viral loads and increased disease severity. Studies have shown that mice deficient in IFN-I production are more susceptible to many viral infections such as vesicular stomatitis virus, Semliki forest virus, vaccinia virus, and lymphocytic choriomeningitis virus than wild-type mice ([@B4]). In human asthma and murine models, HRV infection in the setting of low IFN-I production is closely linked to severe, typically type 2, airway inflammation and increased viral replication, features of disease that are thought to predispose to acute asthma exacerbations ([@B5], [@B6]). HRV induces transcription of numerous genes in the airway mucosa, many of which are IFN responsive genes or closely associated with IFN synthesis ([@B7], [@B8]). *In vitro* studies indicate that HRVs induce a variety of cell types to synthesize IFNs and other cytokines, including lung structural cells such as airway epithelial cells ([@B9]) and fibroblasts ([@B10]), and bone marrow-derived cells such as alveolar macrophages ([@B11]) and plasmacytoid dendritic cells (pDCs) ([@B12]).

Human pDC are characterized as Lin^−^MHC^−^II^+^CD303 (BDCA2)^+^CD304 (BDCA4)^+^ cells ([@B13]) and play a key role in IFN-I production during virus infections ([@B14]). Although a relatively rare cell type \[\~0.4% of total peripheral blood mononuclear cells (PBMCs)\], pDC dedicate much of their transcriptome to IFN synthesis and are prearmed with virus-sensing pattern recognition receptors such as toll-like receptors (TLR7 and TLR9). pDC are able to produce 100--1,000 times more IFN-I than any other cell following exposure to DNA and RNA viruses, and thus are regarded as "natural IFN-I producers" ([@B15]). This has been attributed to the ability to rapidly activate interferon regulatory factor 7 (IRF7), a master regulator of IFN-I expression ([@B16]). This IRF7 signaling pathway within pDC appears especially important for rapidly inducing IFN-I. However, there are considerable knowledge gaps around how pDC regulate HRV-induced immune responses. Transgenic mouse models have been designed to allow conditional depletion of pDC during virus infections, demonstrating the important role of pDC in mediating early antiviral IFN responses ([@B17]). However, confirming these findings in humans presents considerable challenges.

Our group recently developed a system allowing pDC depletion from cultured human PBMC as an indirect but powerful method to better understand human pDC function. This study demonstrated that pDC constrain type 2 responses to HRVs, an important regulatory mechanism that may be deficient in asthma and other allergic disorders ([@B14], [@B18]). To better understand the regulatory properties of human pDC, we therefore undertook a holistic approach using gene expression microarray analysis and pDC depletion in order to (i) determine the effects of HRV on gene expression patterns in PBMC from healthy people and (ii) establish the extent to which these gene expression patterns are dependent on pDC.

Materials and Methods {#S2}
=====================

Study Cohorts {#S2-1}
-------------

The project recruited eighteen healthy adult volunteers (mean age 35 ± 9 years). All subjects answered a questionnaire detailing symptoms of respiratory disease and underwent skin prick testing (SPT) against a panel of nine common inhaled allergens (*Aspergillus fumigatus*, Alternaria, Bahia, Ryegrass, Johnson, Bermuda, house dust mite, cat, and dog dander). All participants had no history of allergic disease or respiratory disease and a negative response to SPT. They had no family history of atopic disease or lung disease and were not taking any supplements or medications at the time when the blood was taken. The Metro South Human Research Ethics Committee approved the study, and all subjects provided written informed consent.

Rhinovirus Generation and Titration {#S2-2}
-----------------------------------

Human rhinoviruses strain 16 (RV16) stocks were generated by passage in Ohio HeLa cells, as described previously ([@B19]) followed by purification over an OptiPrep gradient (Sigma-Aldrich). To define the optimal concentration of RV16, the 50% tissue culture-infective dose (TCID50) was determined as previously described ([@B18]), and all cell stimulations used a multiplicity of infection of 1 (MOI = 1).

PBMC Separation and Depletion of Peripheral pDC {#S2-3}
-----------------------------------------------

Peripheral blood mononuclear cells were isolated from human fresh whole blood by density gradient centrifugation. PBMC were depleted of pDC using CD303 (BDCA-2) immunomagnetic beads with an AutoMACs apparatus according to the manufacturer's instructions (Miltenyi Biotec, Germany). In selected experiments, pDC were also depleted by cell sorting with an Astrios Sorter as per manufacturer's instructions (BD Bioscience) in the Translational Research Institute flow cytometry core facility. Purity of pDC depletions were assessed using flow cytometry as described previously ([@B18]).

Cell Culture and Preparation {#S2-4}
----------------------------

Peripheral blood mononuclear cells or pDC-depleted PBMC were cultured at 2 × 10^6^ cell/ml in media (RPMI 1640 supplemented with 2% heat-inactivated fetal bovine serum (HI-FBS), penicillin, streptomycin, and glutamine) as previously described ([@B20]). Briefly, 250 μl/well cell resuspension was cultured in a 96-well U-bottom plate, with 8 replicates in each group. The cells were rested at 37°C with 5% CO~2~ and 95% humidity overnight and then subsequently stimulated with RV16 or left unstimulated, and further incubated for 24 h. Following culture, plates were centrifuged at 750 × *g* for 5 min and the supernatants were pooled and harvested for cytokine quantification by enzyme-linked immunosorbent assay (ELISA). The cell pellets were pooled and resuspended in 200 µl of RNA protect, and stored in −80°C for RNA extraction using the RNeasy mini kit (QIAGEN, Australia).

Microarray-Based Expression Profiling Studies {#S2-5}
---------------------------------------------

Total RNA from PBMC samples preserved in RNAprotect was extracted by RNeasy mini Kit together with RNase free DNase set (QIAGEN) according to manufacturer's instructions. The quantity and quality of the RNA sample was determined using the Agilent RNA6000 Nano kit on the 2100 Bioanalyzer (Agilent, Amstelveen, The Netherlands). Samples with RNA integrity number \>7 were selected for further analysis. Total RNA samples (*n* = 15) were biotinylated and amplified using the Ilumina^®^ TotalPrep™ RNA Amplification Kit (Ambion, Austin, TX, USA) as per manufacturer's instructions with a standardized input amount of 500 ng. Whole-genome transcriptional profiling was performed using Illumina Human HT-12 microarrays (SanDiego, CA, USA) as per manufacturer's instructions. These were performed by the microarray facility at the Diamantina Institute, University of Queensland. The microarray data were processed and analyzed at Telethon Kids Institute (University of Western Australia, Perth). The raw data are available from Gene Expression Omnibus repository (accession number GSE99858).

Gene Microarray Data Analysis {#S2-6}
-----------------------------

Illumina BeadStudio summary probe and summary control probe profiles were read into R ([@B21]) using the lumiR.batch() function available in the *lumi* package ([@B22]), and using the read.ilmn() function available in the *limma* package ([@B23]). Both *lumi* and *limma* were used to read in the data as each package offers different quality control checks. The proportion of expressed microarray probes for each sample was estimated using the propexpr() function available in the *limma* package, and this check did not reveal any outlying arrays. Background correction and normalization was performed using the neqc() function ([@B24]) available in *limma*, which uses the normal-exponential convolution model for background correction followed by quantile normalization. Distribution of probes for each array was assessed using boxplots and density plots, before and after normalization, and no outlying arrays were identified. The *lumi* package, plotSampleRelation() function, was used to assess sample similarity through multidimensional scaling, and no outlying samples were identified.

12,847 poor quality probes were removed based on annotation from Barbosa-Morais et al. ([@B25]). A further 6,310 non-responding probes were removed based on Illumina's detection *p*-values. The *illuminaHumanv4.db* package ([@B26]) was used to annotate probes with gene symbols and 4,532 probes without gene symbols were removed. 44 samples and 23,634 probes were included in the differential expression analysis. The *limma* package was used for differential expression analysis to test for rhinovirus responsive genes in PBMCs, pDC-depleted PBMCs and for differences in rhinovirus responsive genes in pDC-depleted PBMCs versus PBMCs. Array quality weights were calculated using the arrayWeights() function, and these weights were used in the linear model as a measure of array reliability ([@B27]). Correlation between samples taken from the same individual was adjusted for through use of the duplicateCorrelation() function ([@B28]). *p*-Values were adjusted for multiple testing using the Benjamini and Hochberg method ([@B29]). Three-dimensional principal component analysis (PCA) plots were generated using the *rgl* package ([@B30]) and heat maps were produced using the heatmap.2() function of the *gplots* package ([@B31]).

Upstream Regulator Analysis {#S2-7}
---------------------------

Differentially expressed genes (adjusted *p*-value \< 0.01) were interrogated with Upstream Regulator Analysis (Ingenuity Systems, Redwood City, CA, USA) to identify putative molecular drivers of the observed expression patterns ([@B32], [@B33]). This analysis leverages experimentally derived cause-and-effect molecular relationships extracted from the literature. Two statistical measures are calculated: (i) the overlap *p*-value is based on enrichment of known target genes for each upstream regulator amongst the list of differentially expressed genes and (ii) the activation *Z*-score measures the pattern match between the direction of the observed gene expression changes (up-/downregulation) and the predicted pattern based on prior experimental evidence. An absolute activation *Z*-score greater than 2 was deemed statistically significant ([@B32]).

Real-time PCR (RT-PCR) Validation Studies {#S2-8}
-----------------------------------------

Extracted RNA (500--800 ng per sample) was reverse transcribed using SensiFAST cDNA Synthesis Kit (BIOLINE), according to the manufacturer's instructions. Gene expression was assessed by RT-PCR by LightCycler 480 (Roche Applied Science) with SensiFAST SYBR No-ROX kit (Bioline). *UBE2D2* that has been previously assessed to be stably expressed in PBMC with/without stimulation of RV16 ([@B34]) and *B2M* were used as another reference gene for normalization of the RT-PCR data. Table S1 in Supplementary Material shows the primers sequence used to amplify *CD303, IRF7, IL-27p28, EBI3, IL-15RA, IFI27, IL-12p35, UBE2D2*, and *B2M*. The data was analyzed using the Pfaffl method and the results are expressed as a ratio of stimulated to control (unstimulated) samples, with a fold change of 1.0 representing unstimulated expression levels.

"Rescue Experiments" Using pDC-Depleted Culture Supplemented with Recombinant Cytokines {#S2-9}
---------------------------------------------------------------------------------------

Intact PBMC or pDC-depleted PBMC were preincubated with recombinant human IL-27, IFN-γ, IL-6, IL-15, or IFN-β at 10 ng/ml for 1 or 4 h. Both cell populations were then stimulated with RV16 and further incubated for up to 24 h.

ELISA Assays {#S2-10}
------------

Cytokines were measured in culture supernatants by ELISA according to the manufacturer's instructions. IL-6 and IFN-γ assays used commercially available paired antibodies and recombinant cytokines (BD Biosciences, Franklin Lakes, NJ, USA; limit of detection = 3.91 pg/ml for both cytokines). IL-27 (R&D systems) was assayed *via* commercial ELISA kit (limit of detection = 19.53 pg/ml). IFN-α was measured by VeriKine™ Human IFN-α ELISA kit that detects multiple IFN-α subtypes (PBL assay Science; limit of detection = 12.5 pg/ml).

Intracellular Cytokine Staining {#S2-11}
-------------------------------

Intracellular cytokine staining was used to assess the extent to which IFN-α was produced by different populations, including pDC, myeloid dendritic cells (mDCs), and monocytes, 24 h post-RV16 stimulation. PBMCs (1 × 10^6^ cells/well) were seeded in a 96-U-bottom plate and stimulated with or without RV16 at 37°C with 5% CO~2~ for 18 h, and further incubated with Brefeldin A (BFA) (eBioscience) for 4 h. Cells were washed with FACs buffer (1% HI-FBS in PBS) (FBS; Bovogen biological, Australia) and incubated with normal goat IgG (Sigma Aldrich, USA) at 4°C for 15 min to block non-specific Fc binding. The cells were then surface stained with CD303-PE, CD14-PerCP, and CD1c-FITC (Miltenyi Biotec Australia) for 30 min at 4°C, then fixed and permeabilized prior to APC conjugated anti-IFN-α (Miltenyi Biotec Australia) intracellular staining for 30 min at 4°C. The cells were then washed twice with the FACs buffer, and finally fixed in 0.5% paraformaldehyde prior to analysis. Approximately 200,000 gated events per sample were collected using LSRFortessaX-20 (BD-Biosciences, USA), and the results were analyzed using the FlowJo Tree Star software (version 7.6.1). Unstimulated background values were subtracted from the data.

Pure pDC Culture and Gene Expression Examination {#S2-12}
------------------------------------------------

In some experiments, purified pDC (*n* = 3) isolated from healthy donors by cell sorting were kindly provided by A/Prof Kristen Radford (Mater Research, University of Queensland, Translation Research Institute). Pure pDC (5 × 10^4^ cells/well) were cultured in media supplemented with 10 ng/ml of IL-3 in the presence of absence of RV16 for 24 h.

Statistics {#S2-13}
----------

Statistical analysis was performed using GraphPad Prism 6 for Windows (GraphPad Software, San Diego, CA, USA) using Friedman tests with Dunn's posttests to compare paired samples, whereas Mann--Whitney test was used to compared data from pDC-depleted PBMC and intact PBMC samples. Raw data are presented as mean ± SD. The *p*-values \< 0.05 were considered significant.

Results {#S3}
=======

pDC Depletion Results in a Defective IFN-I Immune Response to RV16 {#S3-1}
------------------------------------------------------------------

We have previously shown that pDC are responsible for more than 90% of the IFN-α production observed in RV16-stimulated human PBMC ([@B12], [@B18]). In the current project, we confirmed that immunomagnetic beads were able to efficiently deplete the pDC population (CD303^+^CD14^−^), with median depletion efficiency of 93% (*n* = 10). A representative flow cytometry plot is shown in Figure [1](#F1){ref-type="fig"}A. This was associated with a profound reduction in median IFN-α production at 24 h from 179.1 to 0.244 pg/ml (*p* \< 0.001; Figure [1](#F1){ref-type="fig"}B). This pDC depletion system therefore provides an ideal means to assess which HRV-activated genes and gene expression pathways are dependent on pDC and/or type I IFN.

![In response to human rhinoviruses strain 16 (RV16) stimulation, plasmacytoid dendritic cell (pDC)-depleted peripheral blood mononuclear cells (PBMCs) produce significantly less interferon (IFN)-α than intact PBMC. PBMC were either depleted of pDC using CD303 immunomagnetic beads or left intact. Efficiency of pDC depletion was examined with flow cytometry **(A)**. PBMC (5 × 10^5^ cells/well) were then cultured in the presence/absence of RV16 (MOI = 1) for 24 h at 37°C. IFN-α production in culture supernatant was measured by enzyme-linked immunosorbent assay (ELISA). Data shown are for the net RV16 simulated IFN-α concentration following subtraction of the IFN-α concentration in the absence of RV16 (media control). The dotted lines represent the median of each group (*n* = 15). IFN-α concentrations in pDC-depleted PBMC were significantly lower than intact PBMC (*p* \< 0.001) **(B)**.](fimmu-08-01351-g001){#F1}

pDC Have a Major Impact on RV16-Activated Genes and Putative Molecular Drivers {#S3-2}
------------------------------------------------------------------------------

Intact PBMC and pDC-depleted PBMC were cultured in the presence or absence of RV16, and gene expression patterns were profiled on microarrays. PCA was employed to provide a global view of the data, and this analysis revealed that the RV16-induced intact PBMC samples clustered separately from RV16-induced pDC-depleted PBMC samples, and also from the unstimulated controls (Figure [2](#F2){ref-type="fig"}A). A heatmap of differentially expressed genes is illustrated in Figure [2](#F2){ref-type="fig"}B. The data showed that the responses were more consistent and intense in intact PBMC. Differential expression analyzes demonstrated that RV16 induced 833 differentially expressed genes in intact PBMC (Figure [3](#F3){ref-type="fig"}A), and 172 differentially expressed genes in pDC-depleted PBMC (Figure [3](#F3){ref-type="fig"}B). A direct comparison of the respective responses revealed 381 differentially expressed genes (Figure [3](#F3){ref-type="fig"}C).

![In the presence of human rhinoviruses strain 16 (RV16), intact peripheral blood mononuclear cell (PBMC) and plasmacytoid dendritic cell (pDC)-depleted PBMCs exhibit distinct patterns of gene expression. Intact PBMC and pDC-depleted PBMC (*n* = 12) were cultured with/without RV16 for 24 h. Whole-genome transcriptional profiling was performed using Illumina Human HT-12 microarray. Hierarchical cluster analysis was employed to cluster genes and samples based on the similarity of their expression patterns. RV16 response patterns in PBMC and pDC-depleted PBMC from healthy individuals (*n* = 11) were analyzed by principal component analysis. RV16-stimulated PBMC are shown in red, unstimulated PBMC are black circles. RV16-stimulated pDC-depleted PBMC are shown in yellow, and unstimulated pDC-depleted PBMC are green circles **(A)**. The heatmap illustrates the distinct difference in the RV16 induced gene expression in PBMC and pDC-depleted PBMC **(B)**.](fimmu-08-01351-g002){#F2}

![Molecular drivers of human rhinoviruses strain 16 (RV16) induced gene expression. Differentially expressed genes/molecular drivers were identified in peripheral blood mononuclear cell (PBMC) **(A,D)** and plasmacytoid dendritic cell (pDC)-depleted PBMC **(B,E)** in the presence of RV16. Comparison of RV16-stimulated pDC-depleted PBMC and intact PBMC **(C,F)**. Data analysis was performed by *limma* **(A--C)** and upstream regulator analysis **(D--F)**. The dashed horizontal line in **(A--C)** indicates FDR \< 0.05. Drivers in red are predicted to be activated and those in blue are inhibited.](fimmu-08-01351-g003){#F3}

We next employed upstream regulator analysis to identify the putative molecular drivers of the observed differential gene expression patterns ([@B33]). Two statistical measures are calculated in this analysis; the *overlap p-value* assesses target gene enrichment amongst the list of differentially expressed genes, whereas the *activation Z-score* measures the degree to which observed gene expression patterns match predicted gene expression patterns based on current knowledge. An activation *Z*-score of \>2 is statistically significant ([@B32]). As illustrated in Figure [3](#F3){ref-type="fig"}D, the most significant candidate drivers of the HRV-stimulated responses in intact PBMC were IFN-γ, TNF, miR-124-3p, IFN-α, and RICTOR. This analysis also suggested that MYCN signaling was downregulated by HRV stimulation. A similar but distinct pattern was observed in pDC-depleted PBMC (Figure [3](#F3){ref-type="fig"}E): IFN-γ, IRF7, IFN-α, and IFN-α2 were again found to be the significant drivers of the HRV-stimulated responses, though in this instance MAPK1, NKX2-3, and TRIM24 signaling were also downregulated. Figure [3](#F3){ref-type="fig"}F highlights the major differences in HRV-stimulated responses observed in pDC-depleted versus intact PBMC. Notably, the activation of many HRV-induced pathways such as IRF7, LPS, IFN-γ, RICTOR, TNF, and IFN-α were deficient in the absence of pDC.

What Proportion of HRV Responsive Genes Are Highly Dependent on pDC and IFN Regulated? {#S3-3}
--------------------------------------------------------------------------------------

In the intact PBMC, RV16 stimulation lead to \>2-fold upregulation of 597 genes and \>2-fold downregulation of 236 genes (Figure [4](#F4){ref-type="fig"}A). We then asked what effect pDC depletion had on these HRV responsive genes. Of the 597 upregulated genes, 249 genes showed a \>2-fold change in the absence of pDC and were arbitrarily regarded as highly pDC dependent, 210 genes showed a modest change in the absence of pDC and were regarded as possibly pDC dependent, while 138 genes were minimally effected by the absence of pDC (\<1.5-fold change) and were regarded as unlikely to be pDC dependent (Figure [4](#F4){ref-type="fig"}B).

![Which human rhinoviruses strain 16 (RV16) responsive genes are dependent on Plasmacytoid dendritic cell (pDC) and regulated by interferon (IFN)-I? RV16 responsive genes showing \>2-fold changes have been analyzed **(A)**. Out of the total genes that are upregulated (Red) or downregulated (Blue), the numbers of pDC-dependent gene expressions have been analyzed by comparing pDC-depleted PBMC with intact PBMC. Genes that show \>2-fold change are regarded as "likely to be pDC dependent"; between 1.5- and 2.0-fold changes are regarded as "possibly pDC dependent"; and \<1.5-fold change and regarded as "unlikely to be pDC dependent" Numbers of genes are indicated on the pie charts **(B,C)**. Out of the total genes that are likely to be pDC-dependent expression (\>2-fold), the proportion of IFN-I-regulated gene expression has been identified using *Interferome v2.01* database: **(D,E)**. Venn diagrams show the extent to which IFN-I-regulated genes are regulated solely by IFN-I, or also regulated by multiple IFN subtypes **(F,G)**.](fimmu-08-01351-g004){#F4}

Of the 236 downregulated genes, 78 genes showed a \>2-fold change in the absence of pDC and were arbitrarily regarded as highly pDC dependent; 127 genes showed a modest change in the absence of pDC and were regarded as possibly pDC dependent, while 31 genes were minimally effected by the absence of pDC and were regarded as unlikely to be pDC dependent (Figure [4](#F4){ref-type="fig"}C).

We then compared our data against *Interferome V2.01*, a publicly available database of type I, II, and III IFN (IFN-II and IFN-III)-regulated genes ([@B35]) in order to infer which of the HRV-responsive and pDC-dependent genes were likely to be IFN-I regulated. Of the 249 HRV-responsive, pDC dependent, upregulated genes that are also pDC dependent (\>2-fold), 99 were regarded as IFN-I-regulated genes (Figure [4](#F4){ref-type="fig"}D), comprising 21 genes which were solely IFN-I regulated, 63 which were IFN-I and IFN-II dual-regulated genes, and 15 which were regulated by IFN-I, IFN-II, and IFN-III (Figure [4](#F4){ref-type="fig"}F). Of the 78 HRV-responsive, pDC-dependent, downregulated genes, 8 were regarded as IFN-I-regulated genes (Figure [4](#F4){ref-type="fig"}E), comprising 0 genes which were solely IFN-I regulated, 7 which were IFN-I/II dual-regulated genes, and none of them were regulated by IFN-I, IFN-II, and IFN-III (Figure [4](#F4){ref-type="fig"}G). None of these HRV-responsive genes appeared to be solely IFN-II regulated or solely IFN-III regulated (Figures [4](#F4){ref-type="fig"}F,G). Thus, while most of the HRV activated upregulated genes are closely linked to pDC and IFN signaling, this is less apparent in the downregulated genes in which IFN signaling appears less prominent.

Validation Experiments {#S3-4}
----------------------

Based on the microarray data and bioinformatics analyzes, HRV-responsive genes were selected for further validation by PCR, focusing on genes whose expression differed markedly between intact PBMC and pDC-depleted PBMC, or alternatively on genes predicted to be important upstream regulators. *IRF7* is regarded as a master regulator of IFN-I ([@B16]) while *IL-27p28, IL-15RA*, and *IFI27* were selected as they were among the most differentially expressed genes (Tables S2A, B in Supplementary Material). IL-27 is a heterodimeric molecule composed of *IL-27p28* and Epstein-Barr virus-induced gene 3 (*EBI3*) subunits, with both proinflammatory and anti-inflammatory functions ([@B36]). Therefore, we have additionally examined *EBI3* (also known as *IL-27B*) as it is the active part of the IL-27 heterodimer, as well as *IL-12p35*, which was included as a negative control (i.e., a gene whose expression was not predicted to be pDC dependent). Moreover, the C type lectin *CD303* (*CLEC4C*), a pDC-specific surface protein, was included to confirm the efficiency of pDC depletion.

In the absence of virus exposure, intact PBMC and pDC-depleted PBMC expressed each of the aforementioned targets to a similar degree, with the exception of *CD303*, which was significantly lower in pDC-depleted PBMC compared to intact PBMC. Consistent with the microarray data, RT-PCR confirmed that *IRF7, IL-27p28, EBI3, IL-15RA*, and *IFI27* mRNA expression was significantly higher in intact PBMC than pDC-depleted PBMC following RV16 stimulation (Figure [5](#F5){ref-type="fig"}A). Note that RV16 induced higher *IRF7* and *EBI3* expression in the intact PBMC, but not in pDC-depleted PBMC. In fact, virus induced downregulation of several genes in the absence of pDC including *IRF7, IL-27, IL-15RA*, and *IFI27*. Expression of *IL-12p35* did not vary in relation to the presence or absence of RV16, or the presence or absence of pDC (Figure [5](#F5){ref-type="fig"}A). Similarly, in response to RV16 exposure, intact PBMC synthesized more IL-6, IFN-γ, and IL-27 protein than pDC-depleted PBMC (Figure [5](#F5){ref-type="fig"}B). Purified pDC produced more IFN-α and less IL-6 than intact PBMC (Figure [S1](#SM1){ref-type="supplementary-material"} in Supplementary Material).

![Validations experiments using real-time PCR (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). Peripheral blood mononuclear cell (PBMC) and plasmacytoid dendritic cell (pDC)-depleted PBMC (*n* = 15) were cultured for 24 h in the absence or presence of human rhinoviruses strain 16 (RV16). mRNA expression of *IRF7, IL-27p28, EBI3, IL-12p35, IL-15RA, IFI27*, and *CD303* was determined by RT-PCR. Data represent fold change relative to median of controls against the average of two reference genes (*UBE2D2* and *B2M*) **(A)**. IL-6 and interferon (IFN)-γ were measured in culture supernatant by ELISA. Net cytokine values are shown (RV16-stimulated cultures minus the unstimulated cultures) **(B)**. All data represent mean ± SD. \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001 (I, intact PBMC; P, pDC-depleted PBMC).](fimmu-08-01351-g005){#F5}

Multiple Cytokines Can "Rescue" IFN-α Production in the Absence of pDC {#S3-5}
----------------------------------------------------------------------

Having shown that multiple RV16 responsive cytokines are pDC dependent, we next sought to determine if adding back any of these missing cytokines would be sufficient to restore the IFN-α response and compensate for the absence of pDC. IFN-β was included as a positive control in these "rescue experiments" as it is known to induce IFN-α. Exogenous IL-15 and IFN-γ had the largest effects amongst all the cytokines tested, restoring IFN-α production, and even boosting it above that seen with RV16 exposed intact PBMC. The effect of exogenous IL-15 was statistically significant (*p* \< 0.01), and while there was a trend for a significant effect of IFN-γ, this was not statistically significant. IL-27 and IL-6 were also able to rescue IFN-α release by virus exposed pDC-depleted cultures (Figure [6](#F6){ref-type="fig"}A). The addition of IL-15, IFN-γ (*p* \< 0.05), or IL-27(*p* \< 0.05) into the intact PBMC also enhance IFN-α release compared to the untreated RV16-stimulated PBMC.

![Addition of certain cytokines to plasmacytoid dendritic cell (pDC)-depleted cultures successfully rescues the interferon (IFN)-α response. Intact peripheral blood mononuclear cell (PBMC) (black bar) and pDC-depleted PBMC (white bar) were precultured with IL-27, IFN-γ, IL-6, IL-15, or IFN-β recombinant protein or with media only for 4 h at 37°C. All samples were subsequently stimulated with human rhinoviruses strain 16 (RV16) \[multiplicity of infection (MOI) = 1\] for a further 20 h. IFN-α protein was measured by ELISA (\**p* \< 0.05; \*\**p* \< 0.01; UT, untreated.) **(A)**, and IFN-α producing cell subsets were measured by Flow Cytometry (\**p* \< 0.05) **(B)**. Data represent mean ± SD.](fimmu-08-01351-g006){#F6}

With intact PBMC, pDC were the most frequent IFN-α producing cell, followed by monocytes, with mDC making a limited contribution. In the absence of pDC, IFN-α producing monocytes were even less frequent. However, supplementing pDC-depleted PBMC with IL-27, IFN-γ, IL-6, or IFN-β enabled monocyte to produce IFN-α. Addition of IL-15 to pDC cultures induced a small amount of IFN-α within mDC (CD1c^+^) (Figure [6](#F6){ref-type="fig"}B).

Discussion {#S4}
==========

In this study, we used a combination of pDC depletion and gene expression profiling to further our understanding of the regulatory properties of pDC in the setting of HRV infection. As expected, pDC depletion led to a major reduction in HRV-induced IFN-α release, and this was associated with profound differences in gene expression between intact PBMC and pDC-depleted PBMC. Upstream regulator analysis suggested that pDC depletion resulted in deficient activation of pathways downstream of IRF7, IFN-γ, RICTOR, and TNF. Interrogation of the data with the Interferome database revealed that almost half of the HRV-induced transcriptome are known to be regulated by IFNs. Validation experiments using qPCR and/or ELISA confirmed many of the changes seen in the microarray, specifically the expression of *IRF7*, the two chains of IL-27 (*IL-*27*p28* and *EBI3*), *IL-15RA*, and *IFI27*, the synthesis of IL-6, IFN-γ and IL-27, and the extent to which these are highly pDC dependent. Finally, "rescue" experiments indicated that IFN-γ, IL-15, IL-27, and IL-6 are all able to compensate for a lack of pDC, restoring the IFN-α response. The extent to which IL-27 is pDC dependent was an important and unexpected finding to emerge from our study.

To our knowledge, our study is the first to show that HRV induces IL-27 expression and that this is pDC dependent. There is some evidence that IL-27 dysfunction contributes to asthma pathophysiology, though little attention has been directed to the role of IL-27 in HRV infections. In a murine asthma model, WSX-1 deficient mice (also known as IL-27Rα^−/−^ mice) exhibited enhanced lung pathology, characterized by goblet cell hyperplasia, infiltration of eosinophils, elevated serum IgE, and airway hyperresponsiveness ([@B37]). In humans, single nucleotide polymorphisms in IL-27p28 are associated with asthma susceptibility, increased IgE, and eosinophilia ([@B38]), while IL-27 expression may play a role in severe asthma ([@B39]). In the current study, we have shown that HRV induces marked IL-27 expression/production that is highly pDC dependent. It has recently been shown that IL-27 in combination with IFN-I and IFN-II can regulate type 2 innate lymphoid (ILC2) cells thereby restricting type 2 immunopathology ([@B40]). IL-27 and IFN-γ can also induce a T~reg~ population (T-bet^+^, CXCR3^+^) that produce higher IL-10 to limit T effector responses, thus reducing infection-induced pathology ([@B41]). Our previous studies have shown that pDC have the capacity to constrain type 2 immune responses to HRV ([@B18], [@B42]). The current study adds to these findings by showing that pDC depletion results in significant reduction of IFN-α, IFN-γ and IL-27 following HRV infection; all three of these cytokines are important regulators that might constrain type 2 response particularly in HRV infection. The extent to which pDC can enhance T~reg~ function and regulate ILC2 cells also warrants further investigation.

HRV induced expression of numerous genes, with profound differences in gene expression between intact PBMC and pDC-depleted PBMC. Many of the differentially expressed genes were associated with the induction of IFN expression, IFN signaling, and initiation of innate immunity. This suggests that pDC play a critical role in the host response to HRV. In the setting of pDC deficiency or pDC dysfunction, individuals are likely to be highly vulnerable to the deleterious effects of this usually innocuous virus. Relative deficiency of circulating pDCs during infancy has been shown to be a risk factor that predicts more frequent and more severe respiratory tract infections, wheezing, and a diagnosis of asthma in later childhood ([@B1]). Interestingly, we have shown that 70--80% of the HRV-responsive genes appear to be pDC dependent; however, Figure [4](#F4){ref-type="fig"} indicates that only a proportion of these are IFN-I dependent. Based on the *Interferome V2.01* database, it appears that only a minority of the total HRV induced gene expressions are solely IFN-I dependent, with additional genes responsive to combinations of type II and type III IFNs. Notably, many of the pDC-dependent expressed genes appear to be IFN independent, highlighting the extent to which pDC regulate additional immune response genes *via* mechanisms that are independent of IFN-I signaling. A role for pDC in limiting immunopathology is well established ([@B14]) and there is emerging evidence that pDC modulate regulatory T-cell function ([@B43]).

Based on the upstream regulator analysis, we identified several HRV-induced molecular drivers that appear to be highly pDC dependent. Others have identified *IRF7* as a master regulator of IFN-I function that is highly expressed in pDC ([@B16]). Similarly, Bosco et al. have identified *IRF7* as a major "hub gene" expressed during asthma exacerbations ([@B44]) and have demonstrated that IRF7 regulates expression of multiple genes in HRV infected human epithelial cells. Not only does *IRF7* knockdown inhibit expression of genes involved in the antiviral response but also enhances expression of proinflammatory genes and oxidative stress response genes ([@B45]). Furthermore, in a murine model of HRV infection, inhibiting IRF7 limited neutrophil and macrophage influx of the lungs, while reducing IFN responses ([@B46]). Additional IFN-I-related genes are also important in establishing an antiviral state during infection. *IFI27* was an additional HRV-induced gene ([@B47]) that was identified in our experiments as being highly pDC dependent. IFI27 can directly inhibit replication and function of hepatitis C virus, another RNA virus ([@B48]) though whether IFI27 has similar effects on HRV is not known.

It is interesting that many of the HRV-responsive genes are not solely IFN-I regulated and require assistance from other types of IFN, particularly IFN-γ. At the 24 h time point, NK cells might be an important source of IFN-γ. Human and mouse models of experimental HRV infection have shown that activation of NK and CD8^+^ T cells requires virus induced expression of IL-15 and its receptor (IL-15Rα) in the nasal and lower airway mucosa ([@B49]). Moreover, in IL-15Rα^−/−^ mice, HRV infection results in a severely impaired IFN-γ expression, CD8^+^ T cell responses, and higher viral load in lung ([@B49]). In this study, we found that HRV stimulation also triggered enhanced IL-15 and IL-15Rα gene expression in human PBMC, but the expression of IL-15Rα was significantly lower in the absence of pDC. Therefore, we propose that low IFN-γ expression in the absence of pDC is likely secondary to deficient IFN-I-dependent IL-15Rα expression that can be partly overcome by provision of exogenous IL-15. In contrast, experimental HRV infections in mice indicate that IL-15 production can be induced independent of type I IFN, though the role of pDC was not examined in that study ([@B49]).

IL-6 is not only a general marker of inflammation but also contributes to inflammatory disease pathogenesis. In our study, HRV-induced IL-6 was also pDC dependent. Though pure pDC can produce IL-6, they are not the primary IL-6 producers, contributing with \<15% of total production (Figure [S1](#SM1){ref-type="supplementary-material"} in Supplementary Material). In allergic asthma, TLR7 activated pDC produce less IL-6, IFN-α, and TNF than pDC from healthy people ([@B50]). This is consistent with our finding that pDC depletion produced significantly lower IL-6 and IFN-α, and somewhat lower TNF-α, consistent with the notion that pDC function might be impaired in asthma. IL-6 signals *via* two types of receptors: membrane-bound IL-6 receptor (mIL-6R) and circulating soluble receptor (sIL-6R), and the use of these receptors can profoundly influence asthma pathogenesis ([@B51]). sIL6 has been shown to be induced by viral infection, and sIL-6R mediated antiviral activation *via* the p28 pathway and IFN-α could promote nuclear translocation of IFN regulatory factor 3 (IRF3) and NF-κB, thereby inducing activation of downstream IFN effector molecules such as 2′5′OAS, PKR, and Mx ([@B52]). It would be interesting for future studies to examine how pDC regulates sIL-6R, and better understand the relationship between sIL-6R, IL-27p28, and downstream IFN stimulatory genes production.

In this study, we have shown that multiple HRV responsive cytokines are pDC dependent, and supplementation with exogenous IL-27, IFN-γ, IL-6, or IL-15 can restore IFN-α response in HRV exposed, pDC-depleted culture. However, if pDC are the primary IFN-α producers ([@B12]), what is the mechanism responsible for this rescued IFN-α production in the absence of pDC? The ability of exogenous IL-27 to rescue IFN-α synthesis in pDC-depleted cultures could be mediated *via* the known ability of IL-27 to activate STAT-1 ([@B39], [@B53]). In addition, IL-27 can induce synthesis of the IFN inducible chemokine CXCL10 (IP-10) in human monocytes ([@B53]). As shown in Figure [6](#F6){ref-type="fig"}B, IL-27, IFN-γ, and IL-6 are all able to induce monocytes to produce IFN-α in the absence of pDC. In contrast, the ability of exogenous IL-15 to rescue IFN-α synthesis does not appear to involve monocytes, but a minor involvement of mDC was observed, so the source of IFN-α synthesis in this situation remains to be determined.

We employed a well-established method by our group to deplete pDC from PBMC *ex vivo*, confirming our previous findings that pDC are the principal IFN-α producer in HRV infection ([@B12], [@B18]). Flow cytometry and RT-PCR expression of CD303 confirmed the efficiency of pDC depletion in the current study. Importantly, HRV exposure *per se* did not modify CD303 expression. Nonetheless, we acknowledge there are a number of limitations of the study. Reagents for protein quantitation for some of the key genes were not commercially available so it was not possible to determine whether all changes in gene expression corresponded to changes in protein expression. The study used only a single strain of HRV (HRV-16), and examined a single time point. The HRV induced innate immune response is mediated by highly conserved pathogen-associated molecular patterns (PAMPs) such as ssRNA, and these are likely to be identical or very similar across multiple HRV strains. There might also be slightly difference between HRV major groups (90%) and HRV minor group (10%) due to the different receptors they use to gain entry to cells, and this needs to be addressed in further studies. Future studies using a wider range of HRV serotypes are necessary to better understand HRV induced adaptive immune response (e.g., antibody responses, T-cell responses), as these are likely to be more variable than innate immune responses. Finally, it is important to highlight the fact that pDC and other circulating immune cells do not usually encounter HRV in the circulation but rather in the airway mucosa, so it is important for future studies to examine interactions between pDC and airway epithelial cells, notwithstanding the technical challenges of such experiments. Nonetheless, our microarray findings provide a significant advance in current understanding of the immune response to HRV. The use of pDC depletion provides a powerful tool to understand the function of this rare but important leukocyte subset.

In conclusion, analysis of HRV activated gene expression patterns indicates the extent to which a small population of pDC are able to exert a profound effect on the immune response. pDC depletion led to major changes in upstream regulator, with 70--80% of the HRV activated genes appearing to be pDC dependent. Several pDC-dependent cytokines were identified, that when added to pDC-depleted cultures, were able to rescue the IFN-α response thereby providing important insight into the mechanisms by which pDC regulate immune responses to HRV. Better understanding of the role of pDC in regulating immune responses to HRV is likely to provide important insights into the reasons why this usually innocuous virus can have serious consequences in certain individuals, and why it is such a common inducer of worsening airway inflammation in those with asthma.
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The cytokine and expression level of genes of interested in pure pDC following RV16 stimulation. FACS purified pDC and PBMC (*n* = 2) were stimulated with RV16 for 24 h. IFN-α and IL-6 protein **(A,B)** in the cultured supernatant were measured using ELISA.
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